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Abstract
DNA-dependent protein kinase (DNA-PK) plays a critical role in DNA damage repair, especially in non-homologous end-
joining repair of double-strand breaks such as those formed by ionizing radiation (IR) in the course of radiation therapy.
Regulation of DNA-PK involves multisite phosphorylation but this is incompletely understood and little is known about
protein phosphatases relative to DNA-PK. Mass spectrometry analysis revealed that DNA-PK interacts with the protein
phosphatase-6 (PP6) SAPS subunit PP6R1. PP6 is a heterotrimeric enzyme that consists of a catalytic subunit, plus one of
three PP6 SAPS regulatory subunits and one of three ankyrin repeat subunits. Endogenous PP6R1 co-immunoprecipitated
DNA-PK, and IR enhanced the amount of complex and promoted its import into the nucleus. In addition, siRNA knockdown
of either PP6R1 or PP6 significantly decreased IR activation of DNA-PK, suggesting that PP6 activates DNA-PK by association
and dephosphorylation. Knockdown of other phosphatases PP5 or PP1c1 and subunits PP6R3 or ARS-A did not reduce IR
activation of DNA-PK, demonstrating specificity for PP6R1. Finally, siRNA knockdown of PP6R1 or PP6 but not other
phosphatases increased the sensitivity of glioblastoma cells to radiation-induced cell death to a level similar to DNA-PK
deficient cells. Our data demonstrate that PP6 associates with and activates DNA-PK in response to ionizing radiation.
Therefore, the PP6/PP6R1 phosphatase is a potential molecular target for radiation sensitization by chemical inhibition.
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Introduction
DNA double-strand breaks (DSBs) arise from normal cellular
processes such as V-D-J recombination and free radicals, as well as
from exogenous sources, such as ionizing radiation or other forms
of genotoxic stress. Homologous recombination (HR) and non-
homologous end-joining (NHEJ) are the two major pathways for
repair of DNA DSBs. NHEJ, which does not require the presence
of a homologous template, is the predominant repair pathway for
DSBs produced by ionizing radiation (IR). The DNA-dependent
protein kinase (DNA-PK) plays a central role in regulating NHEJ,
as evidenced by the hypersensitivity of DNA-PKcs (DNA-PK
catalytic subunit)-/- mice to IR and the high levels of unrepaired
DSBs observed in DNA-PKcs-/- mice after exposure to other
forms of genotoxic agents [1].
DNA-PK has been classified on the basis of sequence analysis as
a member of the phosphatidylinositol-3-kinase (PI-3-K)-related
kinase (PIKK) super family [2], which includes the human ataxia
telangiectasia mutated (ATM) and ATM-Rad3 related (ATR)
proteins. These protein kinases regulate diverse processes,
including genome surveillance and responses to cellular stress
[3,4]. DNA-PK is composed of a catalytic subunit (DNA-PKcs)
and two Ku heterodimers, which act as regulatory subunits [5].
DNA-PKcs contains a DNA binding domain, a catalytic domain,
and a Ku binding domain. NHEJ is initiated when two Ku
heterodimers recognize and stably bind to broken DNA ends,
where they serve to recruit two DNA-PKcs molecules to the
damaged site [6]. Once bound to DNA, the kinase function of
DNA-PKcs is activated. The two separate DNA-PK complexes
interact with each other to bridge the two DNA ends through the
N-terminal HEAT repeats of DNA-PKcs [7]. This interaction
facilitates alignment of the two DNA ends for repair [8,9].
NumerousstudieshaveshownthatDNA-PKcsundergoesa series
of phosphorylations in response to DSBs at the clusters of ABCDE
(six sites between Thr2609 and Thr2647) and PQR (five sites
between residues 2023 and 2056) [10], as well as at additional
conserved sites, including Thr3950 [11,12]. Functional assays have
revealed that phosphorylation at sites in these two clusters regulates
DNA end-access to DNA end-processing factors and to other DNA
repair pathways. Alanine substitution at all six sites of the ABCDE
cluster virtually abolishes the ability of DNA-PK to function in
NHEJ. However, mutating all five sites of PQR to alanine resulted
in only a modest defect in NHEJ. The phosphorylation of ABCDE
promotes end-processing, whereas the phosphorylation of PQR
inhibits end-processing [6]. Thus, the ABCDE and PQR sites
function reciprocally to regulate DNA end-access [12,13]. Phos-
phorylation of the Thr3950 site is thought to be inhibitory, since
mutants mimicking phosphorylation at this site lack kinase activity
without a reduction in the affinity of the catalytic subunit for DNA-
bound Ku. Moreover, impairing the kinase activity of DNA-PKcs
or mutating the clusters of major phosphorylation sites does not
block localization of DNA-PKcs to DSB sites, but lowers the rate of
exchange between DNA-bound and free DNA-PKcs [12–17].
These observations suggest that autophosphorylation is required to
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additional repair steps [8]. Ser/Thr phosphatases, such as PP5 and
PP1c1, are reported to be involved in the regulation of DNA-PK
[18,19]. The overexpression of PP5 decreased DNA-PKcs Thr2609
phosphorylation in HeLa cells, while purified PP1c1 recovered the
DNA-PK activity from autophosphorylated DNA-PKcs in an in vitro
assay. However, little is known about which Ser/Thr phosphatases
regulate DNA-PK activity through dephosphorylation of various
sites in DNA-PKcs.
Protein phosphatase 6 (PP6) is a Ser/Thr protein phosphatase
classified as a type 2A phosphatase family member based on its
sequence homology to the catalytic subunit of protein phosphatase
2A (PP2A) [20] and its sensitivity to active site inhibitors such as
okadaic acid, microcystin and calyculin A [21]. PP6 is functionally
distinct from other type 2A phosphatases and conserved in
evolution, because human PP6 rescues mutations of the homolo-
gous Sit4 in yeast [22]. PP6 plays a role in the regulation of NFkB
signaling [23]. The holoenzyme of PP6 is proposed to be a
heterotrimerthat consists ofa catalyticsubunit(PP6c), a SAPS (Sit4-
Associated Protein) subunit plus an ankyrin repeat subunit (ARS).
The human SAPS, named as PP6R1, PP6R2 and PP6R3, are more
divergent in sequence than PP6 and are widely distributed in
multiple tissues [23]. Recent studies show that siRNA knockdown of
PP6R1, but not PP6R3, enhances degradation of endogenous IkBe
in response to tumor necrosis factor-a (TNF-a) [24]. These results
suggest that one function of the SAPS-like subunit PP6R1 is to
target PP6 to specific substrates such as IkBe.
In this study, we show that DNA-PKcs associates with PP6R1,
that this binding increases after IR, and that depletion of PP6/
PP6R1 reduces IR activation of DNA-PKcs and increases the
radiosensitivity of glioblastoma cells. These observations suggest
that PP6 with a PP6R1 subunit is an important regulator of DNA-
PK activity and function in cells.
Materials and Methods
Cell lines and reagents
DNA-PKcs-proficient (M059K) and DNA-PKcs-deficient
(M059J) glioblastoma cells were maintained in DMEM/F12
media (Invitrogen, Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS, Invitrogen), 0.05 mM non-essential amino
acids (Invitrogen) and 0.5 mM sodium pyruvate (Invitrogen). All
cells were maintained at 37uC with 5% CO2 and were in an
exponential growth phase at the time of radiation. The following
commercial antibodies were used: anti-DNA-PKcs pan mouse
monoclonal, anti-Ku86 mouse monoclonal and anti-tubulin
mouse monoclonal (Santa Cruz Biotechnology, Santa Cruz,
CA); anti-DNA-PKcs Thr2609 phosphospecific rabbit polyclonal
(Abcam, City, State); anti-RPA2 mouse monoclonal and b-actin
mouse monoclonal (Sigma, St. Luis, MO). Anti-PP6 chicken
polyclonal antibody, anti-PP6R1 chicken polyclonal antibody, and
anti-ARSa rabbit polyclonal antibody were provided by the
Brautigan lab. The DNA-PK kinase assay kit was obtained from
Roche. All other reagents were purchased from Sigma.
Radiation treatment
Cells in culture were irradiated with a superficial X-ray machine
atadoserate of1.48Gyperminute.Duringirradiation,the cultures
were maintained in a container designed to mimic the conditions of
the cell culture incubator (5% CO2 and 95% air at 37uC).
Western blot
Whole cell extracts, fractionated extracts and immunoprecipi-
tates were separated by SDS-PAGE and transferred to nitrocel-
lulose membrane. Proteins of interest were detected with specific
antibodies, followed with infrared dye 700 or 800-conjugated
secondary antibodies. Blots were scanned using an Odyssey
infrared imaging system (LI-COR), and proteins were quantita-
tively analyzed by the Odyssey software.
siRNA knockdown
Exponentially growing M059K or M059J cells were transfected
with specific siRNA (50 nM) against PP6c or PP6R1, as described
previously [24], or against DNA-PKcs, PP5, ARSa, PP6R3 or
PP1c1, using LipofectAMINE RNAiMAX (Invitrogen) according
to the manufacturer’s instructions. A nonspecific siRNA (sequence:
59-AAAUCUUCGAGACAUUCUGUU) was used as a control.
All siRNA oligonucleotides were purchased from Dharmacon.
Fluorescent immunostaining
Cells that grew in chamber slides were rinsed once with PBS at
room temperature, fixed with 5% paraformaldehyde at room
temperature for 15 minutes, rinsed twice again with PBS, and
permeabilized with 0.3% Triton X-100/0.3% SDS in PBS for
10 minutes at room temperature. Cells were rinsed 3 times with
PBS and incubated in 5% normal goat serum (MP Biomedical,
City, State) in PBS blocking solution for 30 minutes at room
temperature. Mouse anti-DNA-PKcs or anti-phospho-DNA-PKcs
Thr2609 monoclonal and chicken anti-PP6R1 polyclonal anti-
bodies were diluted 1:100 in 5% goat serum PBS and applied to
the chamber slides for 2 hours at room temperature or overnight
at 4uC. Cells were rinsed 3 times with PBS for 5 minutes each
before staining with the appropriate secondary antibodies,
including fluorescein isothiocyanate (FITC)-conjugated goat anti-
rabbit and Texas red-conjugated goat anti-mouse, and diluted
1:400 in 5% goat serum PBS for 1 hour at room temperature.
Chamber slides were rinsed 5 times again with PBS as described
above and mounted with 10 mL of Vecta-shield mounting medium
containing 200 ng/mL DAPI (Vector Laboratories, Burlingame,
CA). Background staining was determined by preparing identical
chamber slides without primary antibody. Images of fixed cells
were captured with Openlab software using a Nikon fluorescence
microscope (Microphoto-SA) equipped with a Nikon Plan Apo
640 oil immersion objective, filter sets for FITC, Texas Red, and
4,6-diamidino-2-phenylindole fluorophores, and a Hamamatsu
Orca C4742-95 digital camera. Raw data images were converted
to 8-bit tiff images in Openlab.
Cellular fractionation
Cells were collected in ice-cold PBS. The cell pellets were
resuspended for 5 minutes in a permeabilization buffer consisting
of 10 mM HEPES pH 7.4, 10 mM potassium acetate, 50 mg/mL
Digitonin, 1 mM PMSF, 1 mM Na3VO3, and 1 mg/mL protease
inhibitors (aprotinin, leupeptin and pepstatin). The supernatants
were used as a cytoplasmic extract. The pellets were washed with
permeabilization buffer two times and extracted with nuclear lysis
buffer (0.5% Nonidet P-40, 150 mM NaCl, 10 mM sodium
phosphate (pH 7.2), 2 mM EDTA, 50 mM sodium fluoride,
0.2 mM Na3VO3, 1 mM PMSF, and 1 mg/mL aprotinin).
Insoluble material was removed by centrifugation, and the
supernatant was used as a nuclear extract.
Immunoprecipitation
Exponentially growing M059K or M059J cells were irradiated
with 10 Gy IR, then harvested at indicated time points, and lysed
in 1 mL of lysis buffer (0.5% (v/v) NP-40, 5 mM EDTA, 2 mM
EGTA, 20 mM MOPS, 1 mM PMSF, 20 mM sodium pyrophos-
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1m MN a 3VO3, and protease inhibitors) with caspase inhibitor Z-
VAD-FMK. Aliquots of 1 mg total protein were mixed with 4 mg
of monoclonal anti-DNA-PKcs antibody at 4uC overnight. The
bound proteins were recovered by binding to 25 mL of protein-A
agarose (Sigma). The samples were separated by 7.5% SDS-PAGE
gel electrophoresis, then transferred to nitrocellulose overnight and
analyzed by Western blot.
DNA-PK kinase assay
Exponentially growing M059K or M059J cells were treated
with 10 Gy IR. After 30 minutes, the nuclear extracts were
prepared in lysis buffer containing 0.42 M sodium chloride and
1.5 mM magnesium chloride. DNA-PK activity was analyzed
using a DNA-PK activity assay kit (Roche) [13,25] according to
the manufacturer’s instructions.
Clonogenic assay
The method of the clonogenic assay was adapted from Franken,
et al [26]. Briefly, the treated and untreated control cells were
harvested and re-seeded in a 100 mm dish at an appropriate
density to obtain approximately 50–100 colonies. Following 10–
14 days incubation, cells were fixed and stained with crystal violet,
and colonies containing at least 50 cells were scored.
Pulse-field gel electrophoresis
siRNA-transfected cells were sham-treated or irradiated with 10
Gy IR on ice. After irradiation, cells were harvested immediately
or following a 3 hour recovery at 37uC. Harvested cells were
embedded in InCert agarose (BMA, Rockville, MD) plugs and
lysed in 0.5M EDTA, (pH 8), 2% Sarcosyl, 1mg/ml Proteinase K
solution for 48 hours at 50uC. PFGE was carried out using a
CHEF Mapper system (Bio-Rad, Hercules, CA) for 74 hours in
0.8% agarose, 1x TBE buffer at 14uC, with 35 minute pulse time
at the field strength of 2 V/cm and 106 degree included angle. S.
cerevisiae and S. pombe chromosomes (Bio-Rad) were included as
DNA size markers. Following electrophoresis, gels were stained
with ethidium bromide, photographed and analyzed with Image J
software (NIH, Bethesda, MD). The fraction activity released
(FAR) was calculated as an amount of DNA entering the gel
divided by the amount of DNA remaining in the well, and
normalized to sham-irradiated control.
Results
Endogenous DNA-PKcs associates with PP6 and PP6R1
and Responds to Radiation
To investigate potential functions of PP6, we generated a
stable 293 cell line expressing low levels of FLAG-tagged PP6R1
and analyzed immunoprecipitates by mass spectroscopy to identify
interacting proteins [27]. This approach yielded multiple peptides
from a total of .45 PP6R1 interacting proteins, which included
PP6c, ankyrin-repeat PP6 subunits and DNA-PKcs. To follow-up
on this observation, we prepared extracts from the glioblastoma cell
lines M059K and M059J, which do or do not express DNA-PKcs,
respectively, and immunoprecipitated with specific anti-DNA-PKcs
antibodies. Immunoblotting showed endogenous PP6R1 and PP6c
co-immunoprecipitated with endogenous DNA-PKcs from the
proficient M059K cells using specific anti-DNA-PK antibodies, but
not with non-immune IgG used as a negative control (Figure 1,
lanes 1, 2). Using extracts from M059J cells neither PP6 nor PP6R1
were immunoprecipitated and, as expected, no DNA-PK was
recovered (Figure 1, lane 3). These results establish that endogenous
DNA-PKcs, PP6 and PP6R1 are associated in a complex that can
be recovered by immunoprecipitation.
We tested whether the interaction of DNA-PKcs with PP6R1/PP6
was affected by IR. Endogenous DNA-PKcs was immunoprecipitat-
ed from nuclear extracts of M059K cells following various doses of
radiation (0, 5, 10 Gy). Immunoblotting showed identical recovery of
DNA-PKcs in each sample, but increased amounts of co-immuno-
precipitated PP6R1 and PP6c from irradiated vs. non-irradiated cells
Figure 1. PP6R1 associates with DNA-PK in human cancer cells.
A. Cell extracts from irradiated DNA-PK proficient (M059K), and
deficient glioblastoma cells (M059J) were immunoprecipitated with
monoclonal a-DNA-PKcs antibody. Following SDS-PAGE, DNA-PKcs,
PP6R1 and PP6c proteins were detected by immunostaining using
specific antibodies or pre-immune serum. B. M059K cells were
irradiated with 5 or 10 Gy, or sham-treated (0 Gy). One hour after
radiation, the cells were lysed and cytoplasmic and nuclei were
prepared. Nuclei were subjected to immunoprecipitation with DNA-
PKcs antisera. C. Immunoblots of the nuclear fractions were quantified
by densitometry. Standard error bars represent the mean of three
independent experiments (6 SD). The statistical significance of the
differences between the amount of PP6c or PP6R1 in the nuclear
fraction from irradiated cells, and in the nuclear fraction from non-
irradiated control cells was (***, p,0.001) by Student T test.
doi:10.1371/journal.pone.0004395.g001
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significant (1.6 to 2.6-fold) increase in co-precipitation of PP6R1 and
PP6c following 5 Gy of IR (Figure 1C). There was little further
increase in association with DNA-PKcs at 10 Gy compared to 5 Gy,
and the relative- foldincrease in amount of PP6R1 compared to PP6c
when normalized to non-irradiated samples was slightly different, but
the analyses involved immunoblotting with different antibodies for
each subunit. These results showed that following IR there was a
significant increase in the association of endogenous DNA-PKcs with
PP6R1 and PP6c.
DNA-PKcs is required for radiation-induced PP6R1
nuclear localization
DNA-PKcs is a central component of NHEJ that occurs in the
nucleus. Therefore we asked if the IR –induced increase in the
association of PP6R1with DNA-PKcs would affect the intracellu-
lar localization of endogenous PP6R1. We irradiated or mock-
treated M059K and M059J glioblastoma cells, then prepared
nuclear and cytoplasmic fractions that were analyzed by Western
blotting (Figure 2A). After IR of either 5 or 10 Gy the levels of
DNA-PKcs and PP6R1 were higher in the nucleus of M059K cells
compared with non-irradiated (0 Gy) M059K cells. There was a
corresponding decrease in the amount of DNA-PKcs and PP6R1
in the cytoplasmic fractions of irradiated vs. non-irradiated cells.
The IR-induced increase in nuclear DNA-PKcs and PP6R1 was
statistically significant at 5 Gy (Figure 2B) and the translocation
from cytoplasm to nucleus was especially apparent (2.4-fold) with
cells treated with 10 Gy compared to non-irradiated controls.
Ku86 and tubulin were used as loading controls for the total
amount of protein in the nuclear and cytoplasmic fractions,
respectively (Figure 2A). As expected, DNA-PKcs was not detected
by immunoblotting in the cytoplasm or nucleus of deficient M059J
cells. The nuclear vs. cytoplasmic distribution of PP6R1 in DNA-
PKcs deficient M059J cells was not affected by IR. These results
showed that IR induced translocation of DNA-PKcs along with
PP6R1 from the cytosol to the nucleus of glioblastoma cells.
Immunofluorescent microscopy was employed to visualize the
intracellular localization of PP6R1 in response to IR. Endogenous
PP6R1 was distributed in the cytoplasm and nucleus of M059K and
M059J cells (Figure 2C, top row). Following IR there was increased
staining of PP6R1 in the nucleus of M059K cells, but no similar
increase in M059J cells. These results confirmed the cell
fractionationanalysisthat showedIR-inducedPP6R1accumulation
in the nucleus. We also observed an increase in staining for DNA-
PKcs in the nucleus of irradiated M059K cells (data not shown),
however, there was apparent cross-reactivity of the DNA-PKcs
antibodieswithotherproteinsthat gave immunofluorescent staining
of the cytoplasm of both M059K and M059J cells. Phosphosite-
specific antibodies showed phosphorylation of Thr2609 in the
nucleus of DNA-PKcs in irradiated but not control M059K cells.
This staining was not seen following IR of M059J cells that are
deficient in DNA-PKcs (Figure 2C). Taken together our results
indicated that following IR there is an increased association of
DNA-PKcs with PP6R1/PP6c and accumulation of the complex in
the nucleus. The IR-induced nuclear localization of PP6R1 was
seen in cells replete with DNA-PKcs (M059K), but not cells
deficient in DNA-PKcs (M059J), suggesting that the kinase was
required for relocalization of the phosphatase.
Knockdown of DNA-PK abrogates radiation-induced
PP6R1 nuclear localization
We tested the hypothesis that IR-induced nuclear localization of
PP6R1 is dependent on DNA-PKcs. M059K cells were transfected
with a pool of multiple siRNA to knockdown levels of DNA-PKcs
or control siRNA. These cells were then irradiated or mock treated
and compared for the distribution of endogenous PP6R1 by
immunofluorescence microscopy (Figure 3A). In non-irradiated (-
IR) cells transfected with control siRNA or specific siRNA the
PP6R1 appeared predominantly in the cytoplasm compared to the
nucleus, although we noted somewhat enhanced perinuclear
staining and less nuclear staining for PP6R1 in the DNA-PK
Figure 2. IR-induced nuclear localization of PP6R1 is DNA-PK
dependent. A. M059K and M059J cells were left untreated or
irradiated with 5 or 10 Gy. One hour after irradiation, cells were lysed
and fractionated into cytoplasmic and nuclear fractions. The protein
levels of DNA-PKcs and PP6R1 in these fractions were subjected to
immunoblot analysis. b-Tubulin and Ku86 are markers for cytoplasmic
and nuclear fractions, respectively. B. Immunoblots of the nuclear
fractions were quantified by densitometry. The standard error bars
represent means of three independent experiments (6 SD). The
statistical significance of the differences between the amount of DNA-
PKcs or PP6R1 in the nuclear fraction from irradiated cells, compared
with the nuclear fraction of non-irradiated control cells, was (***,
p,0.001) by Student T test. C. M059K and M059J cells grown on
chamber slides were irradiated with 5 Gy, or sham-irradiated. One hour
post-irradiation, cells were fixed and immunostained with PP6R1 and
DNA-PKcs antibodies. Upper row: orange PP6R1 staining, lower row:
green phosphorylated DNA-PKcs Thr2609 stain.
doi:10.1371/journal.pone.0004395.g002
PP6 Regulates DNA-PK Activity
PLoS ONE | www.plosone.org 4 February 2009 | Volume 4 | Issue 2 | e4395knockdown cells. Whereas M059K cells transfected with control
siRNA showed greatly enhanced immunostaining for PP6R1 in
the nucleus following IR, there was no IR-induced change in the
distribution of PP6R1 in M059K cells knocked down for DNA-
PK. As controls and for confirmation, nuclear extracts from
parallel cultures were analyzed by immunoblotting (Figure 3B).
The specific siRNA pool successfully depleted 90% of DNA-PK
from the nuclei of M059K cells. The IR-induced accumulation of
PP6R1 into the nucleus was evident in cells transfected with
control siRNA, and there also was an IR-induced increase in
nuclear DNA-PK, especially when normalized to Ku86 as loading
control. Knockdown of DNA-PK (+lanes) essentially eliminated
any accumulation of PP6R1 in the nucleus, in both irradiated and
non-irradiated cells. One might speculate from this that DNA-PK
is required for transport of the PP6 phosphatase complex into the
nucleus, even in the absence of DNA damage. Ku86 was used as a
loading control for the total amount of nuclear extract protein.
Immunoblotting showed that the total amount of PP6R1 in these
cells was unchanged by either siRNA transfection or IR,
eliminating the possibility that increases or decreases in whole
cell levels of endogenous PP6R1 accounted for the observed
changes in distribution of the protein. Thus, there was cytoplasmic
to nuclear redistribution of PP6R1 in response to IR that was
dependent on expression of DNA-PKcs, supporting the observa-
tions made comparing M059K and M059J cells.
Knockdown of PP6R1 or PP6c reduces activation of DNA-
PK in response to IR
DNA-PKcs contains multiple Ser/Thr phosphorylation sites,
which are known to regulate DNA-PK catalytic and NHEJ
activities. Does the association of PP6R1/PP6 with DNA-PK have
a functional consequence, in terms of kinase activation in response
to IR? To address this question M059K cells were transfected with
pools of specific siRNA to knockdown individual phosphatases
including PP6c, PP5 and PP1c1, or the PP6 subunits PP6R1 or
PP6R3. The activity of DNA-PKcs was analyzed in nuclear
extracts using an in vitro kinase assay with a specific peptide
substrate (Figure 4A). In this assay, DNA-PK activity in M059K
cells transfected with control siRNA was increased about 6-fold in
response to IR (black vs. grey bars). As a control to validate the
assay, there was no detectable kinase activity in DNA-PK deficient
M059J cells, either with or without IR. Knockdown of either
PP6R1 or PP6c resulted in strong, almost complete, suppression of
DNA-PK activity. There was residual IR-induced increase in
DNA-PK in cells knocked down for PP6c or PP6R1, but this level
of IR stimulated activity in the knockdown cells was about the
same as for non-irradiated control cells (grey bars). The effects
were highly selective for PP6 compared to other protein Ser/Thr
phosphatases, even those with reported roles in control of DNA-
PK. M059K cells knocked down for PP5 showed slightly elevated
DNA-PK activity in response to IR, while knockdown of PP1c1
allowed .4-fold kinase activation by IR, and a level of kinase
slightly lower than control. These other Ser/Thr phosphatases,
such as PP5 and PP1c1, may be involved in the regulation of
DNA-PK-mediated DNA repair, but did not directly regulate
DNA-PKcs activity in this assay. Knockdown of another SAPS
subunit for PP6 called PP6R3 did not significantly reduce IR-
induced DNA-PK activity, attesting to the specificity for PP6/
PP6R1. PP6R3 has a SAPS domain and like PP6R1 exclusively
binds PP6 vs. other type-2A phosphatases. These data suggest that
IR activation of DNA-PK requires the non-redundant action of a
PP6 holoenzyme containing a PP6R1 subunit.
In addition, we tested whether PP6R1/PP6 was required for
activation of DNA-PKcs in live cells, using the endogenous
substrate replication protein A2 (RPA2, Figure 4B). RPA2 is
differentially phosphorylated by three PI3Ks (ATM, ATR, DNA-
PK) in response to different DNA damaging agents. However,
DNA-PK is the primary kinase responsible for phosphorylating
RPA2 in response to camptothecin (CPT) treatment [28–30].
Phosphorylation of RPA2 is seen in immunoblotting, by
appearance of a band of reduced mobility relative to the RPA2
band. Camptothecin treatment induced phosphorylation of RPA2
in M059K cells, but not M059J cells. Knockdown of either PP6R1
or PP6 attenuated phosphorylation of the endogenous RPA2 in
response to camptothecin, consistent with a PP6 requirement for
activation of DNA-PK. We concluded that PP6/PP6R1 are
required for activation of DNA-PK in response to two different
DNA damaging agents (IR and CPT).
DSB repair and glioblastoma survival after IR depend on
PP6R1/PP6c
DNA-PK is central to NHEJ of DSB and because PP6R1/PP6 is
required for IR-induced activation of DNA-PK, we wondered if DSB
repair also was dependent on PP6R1 and PP6. We used pulse-field
gel electrophoresis (PGFE) to measure DSBand repair.Glioblastoma
M059K and M059J cells transfected with control siRNA were
compared along with M059K cells transfected with siRNA pools
targeted to PP6R1 or PP6c. Cells were irradiated with 10 Gy IR, and
subjected to PFGE immediately, or 3 hr following radiation to allow
for initial repair. In response to IR about the same level of DSB was
Figure 3. siRNA knockdown of DNA-PKcs abrogates IR-induced
PP6R1 nuclear localization. A. M059K cells were transfected with
control siRNA or anti-DNA-PKcs siRNA, and 48 hours later subjected to 5
Gy. One hour post-irradiation, the cells were fixed and immunostained
with anti-DNA-PKcs and PP6R1 antibodies. Upper row: orange PP6R1
and lower row: merged Dapi ,DNA-PK and PP6R1. B. M059K cells were
transfected with control siRNA or anti-DNA-PKcs siRNA and subjected to
irradiation 48 hours post –transfection. One hour post-irradiation the
cells were fractionated into cytoplasmic and nuclear fractions. The
protein levels of DNA-PKcs, PP6R1, and Ku were detected by
immunoblotting.
doi:10.1371/journal.pone.0004395.g003
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M059K cells approximately 80% of DSB were repaired within 3 hr
after radiation (grey bar), but this response was incomplete in PP6R1
or PP6c-depleted M059K cells, which show persistent DSB, as in the
DNA-PK-deficient M059J cells. Thus, knockdown of either PP6R1
or PP6 mimics the deficiency in DSB repair seen in cells lacking
DNA-PK itself, consistent with an impaired activation of DNA-PK
kinase in response to IR.
Clonogenic survival is the ultimate in vitro assay for cellular
responses to DNA damage. Cells are subjected to different doses of
IR, then plated at limiting dilution and the number of individual
colonies consisting of greater than 50 cells that grow out after a
Figure 4. siRNA knockdown of PP6R1 significantly decreases DNA-PK kinase activity. M059K cells were transfected with control, non-
targeting siRNA or specific siRNAs targeted to PP5, PP1c1, PP6c, PP6R3 and PP6R1. A. Forty-eight hours after transfection, the M059K cells were
irradiated with 5 Gy or sham-irradiated. Thirty minutes after irradiation, cells were harvested and fractionated. DNA-PKcs was immunoprecipitated
from nuclear fractions, and the activity of DNA-PKcs was measured by incorporation of
32P into a DNA-PKcs-specific P53-derived peptide substrate.
DNA-PKcs-deficient M059J cells were used as a negative control. The numbers were normalized to non-irradiated M059K cells and the data show the
mean of counts per minute per mg protein in the eluted solution 6 SD (n=3). B. M059K cells transfected with anti-PP6c or anti-PP6R1 siRNA as
described in panel A were treated with 1 mM CPT for 4 hours. RPA2 was detected in whole cell lysates by Western blot. . The slower migrating band
represents the phosphorylated form of RPA2. M059J cells were used as a negative control.
doi:10.1371/journal.pone.0004395.g004
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initial cells vs. radiation dose. M059K cells transfected with control
siRNA and the DNA-PK deficient M059J cells were assayed to
establish the range of response in the assay, with fewest colonies of
M059J cells (lower line) and the most colonies of M059K cells
(upper line) (Figure 5B). We transfected M059K cells with siRNA
targeting DNA-PKcs, or PP6c, or the PP6 subunits PP6R1,
PP6R3, ARS-A. Cells knocked down for PP6R1 or PP6c exhibited
a survival rate similar to that of DNA-PKcs knockdown cells,
separated above the line for M059J cells (Figure 5B). This response
indicates a higher sensitivity to ionizing radiation. On the other
hand, cells knocked down for the PP6 subunits PP6R3 or ARS-A
were nearly the same as M059K cells transfected with control
siRNA, showing no change in response to IR. Thus, there was a
clear distinction in responses even between different subunits of
PP6. Cell extracts were analyzed by immunoblotting for the level
of the proteins of interest after siRNA transfection (Figure 5C).
These results demonstrate the selectivity and effectiveness of the
siRNA for the various targets, so different responses can be
attributed to depletion of individual proteins. Ku86 was used as
the loading control. We concluded that knock-down of PP6R1/
PP6c enhanced radiation sensitivity of glioblastoma cells to nearly
the same extent as a deficiency of DNA-PK itself.
Discussion
Although the importance of DNA-PK in DNA repair is well
established and has been studied extensively [1,3,5,31,32], the
mechanismbywhichDNA-PKisregulatedinresponsetoIRremains
unknown. The current model is that the ABCDE and PQR clusters
in DNA-PKcs function reciprocally to regulate DNA end-access
[3,10,15]. Phosphorylation of ABCDE promotes end-processing by
Figure 5. siRNA knockdown of PP6R1 or PP6c decreases repair of DNA double-strand breaks and sensitizes glioblastoma cells to
radiation. A. Two days after transfection with siRNA cells were irradiated with 10 Gy and either harvested immediately (10 Gy) or allowed to repair
DNA damage for 3 hours (10 Gy+3 hours) prior to harvesting cells. Harvested cells were embedded in agarose plugs and subjected to PFGE as
described. The bars represent the fraction of DNA released from agarose plugs during PFGE, normalized to sham-irradiated control (6SEM). The data
are from two independent experiments. M059J cells were used as a negative control. B. M059K cells were transfected with control siRNA or specific
siRNAs targeted to DNA-PKcs, PP6R1, PP6c, PP6R3, or ARS-A. Two days after transfection, the M059K cells were irradiated with 0, 2.5, 5 Gy, replated,
cultured for two weeks and scored for surviving colonies. The data points show the mean of surviving fraction 6 SD (n=3). M059J cells were used as
a negative control. C. Representative Western blot for siRNA knockdown efficiency. The blot shows the level of the proteins of interest after
transfection with siRNA. Ku86 is a marker for the nuclear fraction and was used as a loading control.
doi:10.1371/journal.pone.0004395.g005
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end-processing by decreasing accessibility. Phosphorylation-induced
reduction of the protein kinase activity of DNA-PK is restored in vitro
by the addition of the purified catalytic subunit of either PP1c1o r
PP2A and this reactivation is blocked by the potent protein
phosphatase inhibitor microcystin [19]. Moreover, the Wabl group
[18] reported that PP5 interacts with DNA-PK and that overexpres-
sion of PP5 changes the phosphorylation dynamics of two functional
sites: Thr2609 and Ser2056. Another study [15] demonstrated that
mutation to Glu to mimic phosphorylation at the conserved Thr3950
site gave an inactive the kinase, even though this mutation did not
reduce the affinity of the catalytic subunit for DNA-bound Ku. These
observations suggest that the phosphorylation status of DNA-PKcs
could both positively and negatively modulate the DNA repair
activity of DNA-PK.
Our data show that PP6R1/PP6 forms a complex with and
activates DNA-PK in response to DNA damage. Knock-down of
either PP6R1 or PP6c by siRNA significantly reduced the activity
of DNA-PK in cells responding to IR. Thus, dephosphorylation by
PP6, targeted by its PP6R1 subunit, offers a mechanism for the
activation of DNA-PK protein kinase as part of the cellular
damage response. Which sites in DNA-PKcs are the target of PP6
activity remain to be determined. Among the possibilities,
phosphorylation of Thr2609 and Ser2056 was not affected by
depletion of either PP6R1 or PP6c, using reagents available (data
not shown). An inviting alternative is Thr3950, located in the
kinase loop of DNA-PKcs as an inhibitory modification, however,
phosphorylation of this site increased in response to IR [15]. PP6
may dephosphorylate sites in DNA-PKcs to reduce binding with
heterodimer Ku proteins, because DNA-PK activation completely
depends on Ku-mediated complex formation with DNA.
Our data show that endogenous DNA-PK and PP6R1 bind
together, and radiation enhances their association and induces
PP6R1 translocation into, or at least accumulation in, the nucleus.
It is unclear what signal or modification, such as phosphorylation,
triggers formation of the complex. PP6R1 does not have an
obvious nuclear localization sequence. The association of PP6R1
with DNA-PK increases PP6R1 localization in the nucleus,
possibly due to the nuclear import of the DNA-PK. Knock-down
of DNA-PK prevents nuclear localization of PP6R1 and PP6,
supporting the idea of a transport complex. Alternatively, nuclear
DNA-PK could serve as an IR-activated anchor for localization of
PP6R1/PP6 in the nucleus. That idea begs the question of how
PP6 heterotrimers of Mr.450 kDa [27] enter the nucleus.
Increased levels of the PP6R1/PP6/DNA-PK complex in the
nucleus likely facilitate DNA repair and PP6 may have substrates
other than DNA-PKcs. Interestingly, epidermal growth factor
receptor (EGFR) was reported to interact with DNA-PKcs and to
be over-expressed in tumors of epithelial origin [33,34]. IR
induces EGFR import into the nucleus, and inhibition of
radiation-induced EGFR nuclear import by C225 (Cetuximab)
suppressed DNA-PK activity [35]. Thus, EGFR may be involved
in DNA PKcs activation, perhaps involving its kinase activity.
The subunit structure of PP6 has been described to include the
catalytic subunit bound to a SAPS domain present in three different
proteins, named PP6R1, PP6R2, PP6R3 [24]. The SAPS domain
can alone bind PP6, and the SAPS domains in PP6R1, R2 and R3
closely resemble one another. It is possible more than one of the
SAPS subunit might associate with DNA-PK, and this could in part
account for the unequal co-precipitation of PP6R1 and PP6c with
DNA-PK seen in Figure 1. However, siRNA knockdown of PP6R3
had little effect on DNA-PK activation or cell survival compared to
PP6R1 or PP6c. The lack of antibodies for PP6R2 limits experiments
to test these ideas. More recent evidence shows PP6 forms
heterotrimers with the SAPS subunits, binding one of three different
ARS [27]. This does not involve or require the SAPS domain but
instead involves a C terminal region of these PP6 subunits. In this
model the SAPS subunit act as a bridge or scaffold to simultaneously
bind to separate domains the PP6c and the ARS subunit. It is
proposed that the ankyrin repeats in the ARS are used to interact
with substrates or may be involved in localization. Antibody reagents
are only available for ARS-A, not the other proteins and knockdown
of ARS-A by siRNA did not significantly affect clonogenic survival
following IR. Therefore, ARS-A seems not required for PP6 effects
onDNA-PK,andweimagineoneoftheothernewlydiscoveredARS
is involved in the complex with DNA-PK.
Our discovery that PP6 and PP6R1 associate with DNA-PK
and are required for effective kinase activation in response to IR
identify these proteins are possible drug targets for radiation
sensitization. Small molecule selective inhibitors of PP6 are
possible based on differences between PP6 and PP2A [21].
Alternatively, small molecule disruptors of PP6-PP6R1 or PP6R1-
DNA-PK interaction are predicted to be selective in reduction of
the repair response to IR and may be useful in radiotherapy.
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